TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?

The Motley Fool Logo The Motley Fool By David Jagielski
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?

Recursion Pharmaceuticals uses AI for drug discovery, aiming to reduce drug development time and costs. Despite ambitious claims, the company faces significant financial challenges, including substantial losses and ongoing cash burn.

Insights
RXRX   negative

High cash losses ($649.1M), no late-stage drug trials, rising share count, declining stock price, and unproven technology make the investment risky